Perfuze, Ltd. FDA Record
- Latest inspection VAI · May 22, 2024
- No warning letters matched by name
Perfuze, Ltd. has 0 FDA recalls, 1 inspection, 12 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Perfuze, Ltd." is on file.
- Latest inspection
- May 22, 2024 · VAI
- Latest 510(k)
- Nov 5, 2026
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026 | Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026 | Current |
| 510(k) clearances | 12 | Nov 22, 2026 | File dated Nov 18, 2026 | Current |
| Inspections | 1 | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
Reviewing Perfuze, Ltd. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Perfuze, Ltd. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| May 22, 2024 | Dangan, Ireland | Devices | Voluntary Action Indicated (VAI) | 3015701715 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3015701715 | Dangan, Ireland | 1 | May 22, 2024 |
Recent 510(k) clearances
| K-Number | Device | Date |
|---|---|---|
| K261449 | NeuroSheath | Nov 5, 2026 |
| K262399 | Millipede System | Aug 12, 2026 |
| K253901 | Millipede88 Access Catheter | Jul 9, 2026 |
| K253590 | Millipede System | Mar 16, 2026 |
| K252392 | Millipede70 Aspiration Catheter; Perfuze Aspiration Tube Set | Aug 29, 2025 |
| K250012 | Millipede 070 Aspiration Catheter; Perfuze Aspiration Tube Set | Feb 26, 2025 |
| K240711 | Zipline Access Catheter | Oct 17, 2024 |
| K242504 | Millipede 088 Access Catheter; Millipede 070 Aspiration Catheter; Perfuze Aspiration Tube Set | Sep 20, 2024 |
| K233648 | Millipede 088 Access Catheter | Dec 14, 2023 |
| K232524 | Millipede 070 Aspiration Catheter; Perfuze Aspiration Tube Set | Oct 18, 2023 |
| K231802 | Millipede 088 Access Catheter | Sep 19, 2023 |
| K214048 | Millipede 088 Access Catheter | Sep 20, 2022 |
Perfuze, Ltd. and the FDA: common questions
Has Perfuze, Ltd. received an FDA warning letter?
No FDA warning letter addressed to the name "Perfuze, Ltd." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Perfuze, Ltd. received an FDA Form 483?
FDA has not published a Form 483 for "Perfuze, Ltd." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Perfuze, Ltd.?
The most recent FDA inspection on file ended May 22, 2024 at Dangan, Ireland and was classified VAI. FDA has 1 inspection of Perfuze, Ltd. on file.
Need more than this page shows? Ask about Perfuze, Ltd. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.